Dashboard
Weak Long Term Fundamental Strength with a 14.50% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 3.67% signifying low profitability per unit of shareholders funds
With a growth in Net Profit of 85.43%, the company declared Outstanding results in Sep 26
Stock is technically in a Bullish range
With ROE of 9.5, it has a Attractive valuation with a 2 Price to Book Value
Majority shareholders : Promoters
Stock DNA
Pharmaceuticals & Biotechnology
INR 160 Cr (Micro Cap)
20.00
40
0.00%
-0.22
9.55%
2.03
Total Returns (Price + Dividend) 
Latest dividend: 0.959504132231405 per share ex-dividend date: Aug-01-2019
Risk Adjusted Returns v/s 
Returns Beta
News

Below All Moving Averages and Now at Lower Circuit: Makers Laboratories Ltd Loses 5.0% in a Single Session
At Rs 255.24, sellers were still queuing — but there were no buyers willing to take the other side. Makers Laboratories Ltd locked at its lower circuit of 5.0% on 20 Nov 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.
Read More
Makers Laboratories Ltd is Rated Hold by MarketsMOJO
Makers Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 August 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 18 November 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Below All Moving Averages and Now at Lower Circuit: Makers Laboratories Ltd Loses 5.0% in a Single Session
At Rs 271.73, sellers were still queuing — but there were no buyers willing to take the other side. Makers Laboratories Ltd locked at its lower circuit of 5.0% on 17 Nov 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Nov-2026 | Source : BSECopy of Newspaper Publication
Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended 30.09.2026
04-Nov-2026 | Source : BSEStandalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026
Board Meeting Outcome for Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended 30.09.2026
04-Nov-2026 | Source : BSEStandalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026
Corporate Actions 
No Upcoming Board Meetings
Makers Laboratories Ltd has declared 10% dividend, ex-date: 01 Aug 19
No Splits history available
No Bonus history available
Makers Laboratories Ltd has announced 1:5 rights issue, ex-date: 30 Mar 22
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Kaygee Investments Private Limited (36.88%)
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs (2.83%)
31.47%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 12.72% vs 19.64% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 163.33% vs 37.61% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 16.94% vs 18.15% in Sep 2024
Growth in half year ended Sep 2025 is -95.91% vs 327.62% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 20.73% vs 13.41% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -83.27% vs 251.20% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 16.43% vs 15.67% in Mar 2025
YoY Growth in year ended Mar 2026 is -68.62% vs 219.65% in Mar 2025